Lumexa forecasts Q2 2026 adjusted EBITDA between $235M and $241M
Lumexa Imaging Holdings, Inc. expects adjusted EBITDA of $235M-$241M in Q2 2026.
The company’s joint venture expansion with Hospital for Special Surgery is a key factor in its growth strategy.
Lumexa’s CEO highlighted strong same-center growth and an expanding mix of services as drivers of progress.